Everest Medicines (äŗ锶ę°č) IPO: Overvalued for the Portfolio but Sentiment Is Strong
Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and biotechs....
520 Views
ECM Weekly (27 September 2020) - Ant Group, Chindata, SCG Packaging, JHBP/Genor, Neuedu, UTI AMC
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Deal...
491 Views
Everest Medicines IPO Initiation: Potent Medicine
Everest Medicines Everest Medicines (EVEREST HK)Ā is a biopharmaceutical company which targets four therapeutic areas - oncology, immunology,...
522 Views
Everest Medicines (äŗ锶ę°č) Pre-IPO: Thoughts on Valuation
Everest Medicines is a China-based biotech company with late-stage drug candidates in-licensed from partner pharmaceutical companies and...
706 Views
ECM Weekly (20 September 2020) - Ant Group, Ming Yuan Cloud, Neusoft Edu, Computer Age Mgt
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Hong...
504 Views